Vinicius Adami Vayego Fornazari, Renato Abu Hana, Raphael Brandão Moreira, Carlos Alexandre de Freitas Trindade, Thiago Franchi Nunes
{"title":"Before Treating the Lesion, Identify the Pain Generator: Rethinking Cancer Pain in Interventional Oncology.","authors":"Vinicius Adami Vayego Fornazari, Renato Abu Hana, Raphael Brandão Moreira, Carlos Alexandre de Freitas Trindade, Thiago Franchi Nunes","doi":"10.1007/s00270-026-04655-5","DOIUrl":"https://doi.org/10.1007/s00270-026-04655-5","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kuran Rati, Sairah Khan, Samir Mahboobani, Jayanta Nandi, Ali Alsafi
{"title":"Occult Hypervascularity of an Endobronchial Carcinoid Demonstrated by Bronchial Angiography.","authors":"Kuran Rati, Sairah Khan, Samir Mahboobani, Jayanta Nandi, Ali Alsafi","doi":"10.1007/s00270-026-04651-9","DOIUrl":"https://doi.org/10.1007/s00270-026-04651-9","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Access Vessel Patency After Endovascular Therapy via Tibiopedal Access in Patients With Lower Extremity Artery Disease.","authors":"Haruya Yamane, Yasunori Ueda, Kazuho Ukai, Kuniyasu Ikeoka, Haruhiko Abe, Koichi Inoue, Yasushi Matsumura","doi":"10.1007/s00270-026-04660-8","DOIUrl":"https://doi.org/10.1007/s00270-026-04660-8","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the access vessel patency after endovascular therapy performed via tibiopedal access.</p><p><strong>Materials and methods: </strong>This was a retrospective, single-center, observational study. Patients who underwent endovascular therapy via tibiopedal access with sheath insertion were enrolled. The primary outcome was loss of access vessel patency defined as access vessel occlusion or stenosis with a peak systolic velocity ratio > 2.4 on duplex ultrasound at 6 months. Multivariate logistic regression analysis was performed to identify the predictors of access vessel patency loss, with hemodialysis, severely calcified access vessel and sheath-to-artery ratio included as covariates.</p><p><strong>Results: </strong>A total of 95 limbs in 91 patients were included in this study, and loss of access vessel patency was observed in 22 limbs (23.1%). Multivariate logistic regression analysis demonstrated that sheath-to-artery ratio was the only independent predictor (odds ratio: 1.493, 95% confidence interval: 1.130-1.976; p = 0.005). The receiver operating characteristic curve analysis revealed that the optimal cutoff value of sheath-to-artery ratio for predicting loss of access vessel patency was 1.08, with an area under the curve of 0.723. In this cohort, the 2-year freedom from major adverse limb events were 98.6% (95% CI: 90.8-99.8%), and no major amputation occurred.</p><p><strong>Conclusion: </strong>The present study demonstrated a relatively high incidence of loss of access vessel patency after endovascular therapy via tibiopedal access, although this was not associated with an increase in major adverse limb events. A larger sheath-to-artery ratio was identified as an independent predictor of loss of access vessel patency.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Taheri Amin, I E Martínez Safar, F Collettini, R T Hoffmann, M Katoh, B M Schaarschmidt, F Wacker, P Minko
{"title":"Technique, Safety and Adoption of Genicular Artery Embolization for Knee Osteoarthritis: A Nationwide Analysis of the German Quality-Assurance Registry.","authors":"A Taheri Amin, I E Martínez Safar, F Collettini, R T Hoffmann, M Katoh, B M Schaarschmidt, F Wacker, P Minko","doi":"10.1007/s00270-026-04657-3","DOIUrl":"https://doi.org/10.1007/s00270-026-04657-3","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the nationwide adoption of genicular artery embolization (GAE) in Germany and to describe patient selection, technique, safety and radiation dose.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed procedures recorded in the quality-assurance registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR), from January 2024 to December 2025. Technical success, entered per procedure, was defined as subjective adequate devascularization of the synovial blush. Complications were graded using the modified CIRSE classification, and radiation exposure was expressed as dose-area product (DAP) and fluoroscopy time. The analysis was primarily descriptive.</p><p><strong>Results: </strong>Overall, 2335 procedures in 2209 patients across 109 centers in 15 federal states were recorded (median age 67 years, IQR 59-77; 57% female; prior total knee arthroplasty (TKA) in 300, 13%). Annual volume rose from 579 procedures in 2024 to 1,756 in 2025, and the embolic agent shifted from permanent (40-21%) toward temporary microspheres (4-29%). Center-reported technical success was 93% (87% in 2024, 94% in 2025). Eleven complications were recorded (0.5%), all CIRSE grade 1-3, with no permanent sequelae; none were recorded in 2024. Median DAP was 1536 cGy cm<sup>2</sup> (IQR 731-3048) and median fluoroscopy time 24 min (IQR 16-34).</p><p><strong>Conclusion: </strong>During rapid nationwide adoption, GAE was performed for osteoarthritis-related and post-TKA pain with low radiation dose and high center-reported technical success across centers of all volumes, supporting its feasibility in routine practice. The complication rate is a lower limit, as the registry is not designed for complication surveillance.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pierleone Lucatelli, Laura Crocetti, Renato Argirò, Roberto Iezzi, Chiara Reale, Valeria Grillo, Tetyana Shchipska, Alessandro Maresca, Marcello Lippi, Elena Bozzi, Roberto Cioni, Matteo Madonna, Marta Pignataro, Mario Corona, Valeria Panebianco, Carlo Catalano, Andrea Gallivanone, Nicolò Schiesaro, Agnese Bonino, Vittorio Pedicini, Andrea Laghi, Ezio Lanza
{"title":"Cost Analysis of Percutaneous Segmentectomy Versus Chemoembolisation and Radioembolisation in Hepatocellular Carcinoma: A Retrospective Multicentre Cohort Study.","authors":"Pierleone Lucatelli, Laura Crocetti, Renato Argirò, Roberto Iezzi, Chiara Reale, Valeria Grillo, Tetyana Shchipska, Alessandro Maresca, Marcello Lippi, Elena Bozzi, Roberto Cioni, Matteo Madonna, Marta Pignataro, Mario Corona, Valeria Panebianco, Carlo Catalano, Andrea Gallivanone, Nicolò Schiesaro, Agnese Bonino, Vittorio Pedicini, Andrea Laghi, Ezio Lanza","doi":"10.1007/s00270-026-04647-5","DOIUrl":"https://doi.org/10.1007/s00270-026-04647-5","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the costs of percutaneous segmentectomy, a single-session combination of transarterial embolisation and microwave ablation, against chemoembolisation and radioembolisation for hepatocellular carcinoma.</p><p><strong>Materials and methods: </strong>Retrospective cost analysis of 66 patients treated with percutaneous segmentectomy at five Italian centres, using bottom-up micro-costing. Comparator costs were derived from published Italian per-session costs multiplied by mean sessions per patient, and survival from published curves. A partitioned survival model estimated life-years and incremental net monetary benefit at 50,000 euros per life-year.</p><p><strong>Results: </strong>Procedural cost per treated patient was 6331 euros for percutaneous segmentectomy, 9792 euros for chemoembolisation (mean 2.94 sessions), and 21,673 euros for radioembolisation (1.52 sessions). At 24 months, percutaneous segmentectomy had lower total cost and a small life-year deficit (incremental cost-effectiveness ratio approximately 70,800 euros per life-year versus chemoembolisation and 57,500 versus radioembolisation, both above threshold). This life-year-adjusted advantage reversed versus chemoembolisation, and became neutral versus radioembolisation, in a worst-case sensitivity analysis, and reversed against both when transplantation costs for the eight transplanted patients (19%) were attributed to percutaneous segmentectomy alone.</p><p><strong>Conclusion: </strong>In this exploratory analysis, percutaneous segmentectomy appeared to have a lower procedural cost per treated patient than chemoembolisation and radioembolisation, mainly because it is delivered in a single session. However, because costing routes, cohorts, and survival sources were not equivalent and the life-year-adjusted comparison was not robust, no formal cost superiority can be established. These hypothesis-generating findings require confirmation in prospective, matched studies.</p><p><strong>Level of evidence: </strong>Level 4, Retrospective Cohort Study with Historical Comparators.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Denis Gholami Bajestani, C Martin Reich, Jan Birkigt, Christina Mulik, Johannes Kauffold, Haukur Lindberg Sigmarsson, Thies Jochimsen, Bernhard Sattler, Osama Sabri, Michael Steinmetz, Andreas Melzer
{"title":"Multistage Preclinical Evaluation of MRI-Guided Stenting for Coarctation of the Aorta using in vitro and Porcine Models.","authors":"Denis Gholami Bajestani, C Martin Reich, Jan Birkigt, Christina Mulik, Johannes Kauffold, Haukur Lindberg Sigmarsson, Thies Jochimsen, Bernhard Sattler, Osama Sabri, Michael Steinmetz, Andreas Melzer","doi":"10.1007/s00270-026-04642-w","DOIUrl":"https://doi.org/10.1007/s00270-026-04642-w","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluated the technical and procedural feasibility of MRI-guided stent implantation for CoA using a structured multistage preclinical evaluation protocol.</p><p><strong>Materials and methods: </strong>A commercially available MR Conditional guidewire and dedicated research prototypes comprising nitinol stents, delivery systems, and balloon catheters were assessed in a three-stage protocol. Device visibility was evaluated in a standardized water phantom at 1.5 T and 3.0 T. In a polymer-based CoA vessel phantom, 10 stent implantations were performed by novices (n = 6) and experts (n = 4), with four separate expert-led balloon dilatations. MRI-guided stent implantation was subsequently performed in five porcine models.</p><p><strong>Results: </strong>All devices were visible at both field strengths, with lateral artifact widths of 5.3-7.8 mm for the guidewire, 20.9-38.5 mm for the stent delivery system, 13.1-19.9 mm for the expanded stents, and 17.4-30.5 mm for the balloon catheter. Phantom stenting duration was 10.2 ± 7.2 mins for novices and 6.2 ± 2.7 mins for experts. MRI-guided stent implantation was successfully performed in all five animals, with a mean duration of 13.6 ± 7.5 mins. In one animal, balloon post-dilatation was additionally performed as a procedural proof of concept.</p><p><strong>Conclusion: </strong>MRI-guided stent implantation for CoA is feasible within a structured multistage preclinical evaluation protocol and supports further clinical translation of radiation-free endovascular treatment.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149214959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Balloon-Occlusion Versus End-Hole Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.","authors":"Salvatore Tumolo, Afonso Quelhas Fonseca, Vincenzo Vingiani, Tiago Bilhim, Hüseyin Saygin Tuna","doi":"10.1007/s00270-026-04645-7","DOIUrl":"https://doi.org/10.1007/s00270-026-04645-7","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the efficacy and safety of balloon-occluded transarterial chemoembolization (B-TACE) compared with conventional (cTACE) and drug-eluting-bead transarterial chemoembolization (DEB-TACE) in patients with hepatocellular carcinoma.</p><p><strong>Materials and methods: </strong>A systematic review and meta-analysis was conducted following PRISMA guidelines and registered in PROSPERO. PubMed, Scopus, and the Cochrane Central Register of Controlled Trials were searched to 8 February 2026 for randomized and observational studies comparing B-TACE with cTACE or DEB-TACE. Tumor response (mRECIST), overall survival, and adverse events were pooled using random-effects models; risk of bias was assessed with established tools.</p><p><strong>Results: </strong>Nine studies (one randomized, eight observational; 1534 patients) were included. Complete response, objective response, disease control, and progressive disease did not differ significantly between groups, with moderate-to-substantial heterogeneity. Baseline tumors were larger in the balloon-occluded group (mean difference 4.34 mm; 95% CI 1.18- 7.50; p = 0.014). Exploratory study-level analyses suggested greater relative B-TACE effects with larger tumors, particularly for complete response and disease control.Overall survival favored B-TACE in the two studies with extractable hazard ratios (HR 0.41; 95% CI 0.23 to 0.73; p = 0.002). Post-treatment liver enzymes, bilirubin, fever, and post-embolization syndrome did not differ significantly.</p><p><strong>Conclusion: </strong>No statistically significant differences in imaging response or safety were observed between intervention and comparator groups, while B-TACE was associated with a signal toward improved overall survival despite larger baseline tumors. Exploratory findings suggested that larger tumor size may be associated with a greater relative B-TACE effect. Given the limited evidence, these findings require confirmation in randomized controlled trials.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149191321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}